ZYLOX-TONBRDG.MED.TECH.H1 (818) — Net Asset Quality Index
ZYLOX-TONBRDG.MED.TECH.H1 (818) has a Net Asset Quality Index of 90.2% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €3.50 Billion minus total liabilities of €341.97 Million yields net assets of €3.15 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read ZYLOX-TONBRDG.MED.TECH.H1 (818) financial obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
ZYLOX-TONBRDG.MED.TECH.H1 Net Asset Quality Index Over Time (2021–2024)
This chart shows how ZYLOX-TONBRDG.MED.TECH.H1's Net Asset Quality Index has evolved across 4 annual periods from 2021 to 2024. As of June 2025, the index stands at 90.2%, representing net assets of €3.15 Billion against total assets of €3.50 Billion EUR. For live market cap and overall valuation, see how much is ZYLOX-TONBRDG.MED.TECH.H1 worth.
Annual Net Asset Quality Index for ZYLOX-TONBRDG.MED.TECH.H1 (2021–2024)
The table below presents the year-by-year Net Asset Quality Index for ZYLOX-TONBRDG.MED.TECH.H1 from 2021 to 2024, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See what is ZYLOX-TONBRDG.MED.TECH.H1's book value for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 89.8% | €3.10 Billion | €3.45 Billion | €351.56 Million | ▼ -0.5 pp |
| 2023 | 90.3% | €3.05 Billion | €3.38 Billion | €328.32 Million | ▼ -4.8 pp |
| 2022 | 95.1% | €3.09 Billion | €3.25 Billion | €159.54 Million | ▼ -1.7 pp |
| 2021 | 96.8% | €3.14 Billion | €3.25 Billion | €103.61 Million | — |